Biliary Tract Cancer | ABC Trial (AG0403BT)
A phase II trial of gemcitabine in fixed rate dose infusion combined with cisplatin in patients with inoperable biliary tract carcinomas.
Schema
Summary
Biliary tract cancers are uncommon; as a result it is not a well-studied disease and treatment options for this condition are limited. This study will assess the impact of a new combination of chemotherapy drugs on the growth of the cancer and the undesirable side-effects of treatment.
